Send to friend Linked
Alnylam Pharmaceuticals
|
| Website | http://www.alnylam.com/ |
|---|---|
| Location | Boston |
| Industry | Healthcare & Pharmaceuticals |
| Revenue | unknown |
| Investment | unknown |
| Growth | unknown |
| Employees | unknown |
Alnylam Pharmaceuticals, a leader in RNAi therapeutics, is a biopharmaceutical company developing novel therapeutics based on a breakthrough in biology known as RNA interference, or RNAi; a discovery that enables the creation of a broad new class of human therapeutics. Using RNAi, Alnylam has built a product engine to develop a deep pipeline of drug products to treat a wide array of important diseases.
-
News: It's Wait Until Next Year for These Drugmakers
-
News: Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication ...
-
News: Gene "silencing" drug blocks heart disease in mice
-
News: Regulus Therapeutics, Alnylam Pharmaceuticals, and Collaborators Publish First Ever In Vivo Efficacy Data for a ...
-
News: Biotech Mailbag: All About Alnylam
-
News: Alnylam to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference
-
News: Alnylam sees results for liver disease treatment
-
News: Alnylam Presents Pre-clinical Data from TTR Amyloidosis Development Program
-
News: Mayo Clinic Develops Potential New Therapy To Stop The Progression Of Parkinson's Disease
-
News: Not just a messenger boy!
4 Available Jobs